Journal of Oncology Practice
2014-12-01
Risk and Consequences of Chemotherapy-Induced Febrile Neutropenia in Patients With Metastatic Solid Tumors.
Derek Weycker, Xiaoyan Li, John Edelsberg, Rich Barron, Alex Kartashov, Hairong Xu, GaryH Lyman
Index: J. Oncol. Pract. , (2014)
Full Text: HTML
Abstract
Although studies have evaluated the risk and consequences of febrile neutropenia (FN) among patients receiving cancer chemotherapy in US clinical practice, none have focused on a broad group of patients with metastatic disease.
Related Compounds
Related Articles:
Analysis of fentanyl in urine by DLLME-GC-MS.
2015-03-01
[J. Anal. Toxicol. , (2014)]
2014-01-01
[J. Cancer 5(8) , 706-14, (2014)]
2015-02-01
[J. Sep. Sci. , doi:10.1002/jssc.201401123, (2014)]
2014-11-01
[Eur. Rev. Med. Pharmacol. Sci. 18(22) , 3517-20, (2014)]
2015-06-01
[J. Endourol. , (2014)]